RGH-706

· Gedeon Richter Plc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGH-706, covering 2024-06-03 to 2024-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome [Phase 2]